In the deal, Roche is adding CT-388, a Phase-2 ready, weekly-administered dual GLP-1/GIP receptor agonist for treating obesity in patients with and without type 2 diabetes
This has sparked interest in NAD+ boosting therapies to promote healthy aging
You Don't Know What's in the Vial Third-party testing of "research" peptides has found: wrong peptide entirely, incorrect concentrations (sometimes 50% under or over), bacterial endotoxins, heavy metal contamination, and residual solvents from manufacturing
How to take Acetyl L Carnitine
Cash-paying customers can buy injector pens for $499 per month
If we want to allow for these potentially miracle peptides to be available to the mainstream we must figure out a way to do it in a more responsible way